The Outcome of Patients with Platinum-Resistant/Refractory Ovarian Cancer Treated with the Combination of Pegylated Liposomal Doxorubicin and Gemcitabine

Authors

Vijaya Galic MD, MBA, Lehigh Valley Health Network
Richard Boulay MD, Lehigh Valley Health NetworkFollow
M Bijoy Thomas MD, Lehigh Valley Health NetworkFollow
Cody Gillenwater, Lehigh Valley Health Network
Christine C. Chen MD, Lehigh Valley Health NetworkFollow
Martin Martino MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

3-2010

Comments

Copyright © Lehigh Valley Health Network

Published In/Presented At

Galic, V., Boulay, R., Thomas, M., Gillenwater, C., Chen, C., & Martino, M. (2010, March 14-14). The outcome of patients with platinum-resistant/refractory ovarian cancer treated with the combination of pegylated liposomal doxorubicin and gemcitabine. Poster presented at: The Society of Gynecologic Oncologists (SGO) 41st Annual Meeting, San Francisco, CA.

Disciplines

Medical Specialties | Medicine and Health Sciences | Obstetrics and Gynecology | Oncology

Department(s)

Department of Obstetrics and Gynecology, Department of Obstetrics and Gynecology Faculty, Department of Obstetrics and Gynecology Residents

Document Type

Poster